Related Experiment Video
Updated: Mar 2, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in
Heath D Skinner1, Uma Giri2, Liang P Yang3
1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. hskinner@mdanderson.org.
Abstract:
Purpose: The primary cause of death due to head and neck squamous cell carcinoma (HNSCC) is local treatment failure. The goal of this study was to examine this phenomenon using an unbiased approach.Experimental Design: We utilized human papilloma virus (HPV)-negative cell lines rendered radiation-resistant (RR) via repeated exposure to radiation, a panel of HPV-negative HNSCC cell lines and three cohorts of HPV-negative HNSCC tumors (n = 68, 97, and 114) from patients treated with radiotherapy and subjected to genomic, transcriptomic, and proteomic analysis.Results: RR cell lines exhibited upregulation of several proteins compared with controls, including increased activation of Axl and PI3 kinase signaling as well as increased expression of PD-L1. Additionally, inhibition of either Axl or PI3 kinase led to decreased PD-L1 expression. When clinical samples were subjected to RPPA and mRNA expression analysis, PD-L1 was correlated with both Axl and PI3K signaling as well as dramatically associated with local failure following radiotherapy. This finding was confirmed examining a third cohort using immunohistochemistry. Indeed, tumors with high expression of PD-L1 had failure rates following radiotherapy of 60%, 70%, and 50% compared with 20%, 25%, and 20% in the PD-L1-low expression group (P = 0.01, 1.9 × 10-3, and 9 × 10-4, respectively). This finding remained significant on multivariate analysis in all groups. Additionally, patients with PD-L1 low/CD8+ tumor-infiltrating lymphocytes high had no local failure or death due to disease (P = 5 × 10-4 and P = 4 × 10-4, respectively).Conclusions: Taken together, our data point to a targetable Axl-PI3 kinase-PD-L1 axis that is highly associated with radiation resistance. Clin Cancer Res; 23(11); 2713-22. ©2017 AACR.
Insights
Local treatment failure in head and neck squamous cell carcinoma (HNSCC) is linked to increased PD-L1 expression. Targeting the Axl-PI3 kinase-PD-L1 axis may overcome radiation resistance in HNSCC patients.
Area of Science:
- Oncology
- Radiation Oncology
- Cancer Biology
Background:
- Head and neck squamous cell carcinoma (HNSCC) often results in death due to local treatment failure.
- Understanding the mechanisms of radiation resistance is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the molecular mechanisms underlying local treatment failure in HNSCC.
- To identify potential therapeutic targets for overcoming radiation resistance.
Main Methods:
- Utilized radiation-resistant (RR) HPV-negative HNSCC cell lines and patient tumor cohorts.
- Performed genomic, transcriptomic, and proteomic analyses, including Reverse Phase Protein Arrays (RPPA) and immunohistochemistry.
- Correlated protein and gene expression with clinical outcomes following radiotherapy.
Main Results:
- Radiation-resistant cell lines showed increased expression of Axl, PI3 kinase signaling, and PD-L1.
- Inhibition of Axl or PI3 kinase reduced PD-L1 expression.
- High PD-L1 expression in patient tumors significantly correlated with local treatment failure after radiotherapy (failure rates of 50-70% vs. 20-25%).
- Low PD-L1 expression combined with high CD8+ tumor-infiltrating lymphocytes was associated with no local failure or disease-related death.
Conclusions:
- A targetable Axl-PI3 kinase-PD-L1 signaling axis is strongly associated with radioresistance in HNSCC.
- This axis represents a potential therapeutic strategy to enhance radiotherapy efficacy.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Intracellular Signaling Affects Focal Adhesions
Some...